The Oxford team erroneously claimed that dexamethasone was the first medication to improve the survival of seriously ill Covid-19 patients. Other treatments also show promise.
A Dutch study released this week confirms that some patients who experience so-called mild symptoms from Covid-19 turn out to be substantially burdened by the disease for long periods of time, sometimes months.
Though officials have been keeping track of the number people infected and dead by Covid-19, there are no numbers regarding the number of people living with lifelong injury because of the disease.
A recent report found that those with type A blood were at increased risk for respiratory failure, while type O blood had a protective effect. What do these findings mean?
The coronavirus crisis has been a catalyst in substantially broadening telehealth services and reimbursement. With patient non-adherence to prescription regimens still stuck at as high as 50% telehealth may offer a path forward to effectively address t…